News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,791 Results
Type
Article (87528)
Company Profile (807)
Press Release (774434)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233093)
Career Advice (4140)
Deals (39811)
Drug Delivery (140)
Drug Development (91280)
Employer Resources (203)
FDA (18297)
Job Trends (17407)
News (397484)
Policy (39929)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (129)
Alliances (56980)
ALS (147)
Alzheimer's disease (1690)
Antibody-drug conjugate (ADC) (267)
Approvals (18335)
Artificial intelligence (515)
Autoimmune disease (104)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (139)
Brain cancer (53)
Breast cancer (527)
Cancer (4166)
Cardiovascular disease (361)
Career advice (3562)
Career pathing (38)
CAR-T (256)
CDC (57)
Cell therapy (710)
Cervical cancer (33)
Clinical research (75805)
Collaboration (1446)
Company closure (4)
Compensation (963)
Complete response letters (62)
COVID-19 (2962)
CRISPR (85)
C-suite (624)
Cystic fibrosis (141)
Data (4926)
Decentralized trials (2)
Denatured (64)
Depression (113)
Diabetes (465)
Diagnostics (7108)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (245)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (209)
Earnings (99187)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133492)
Executive appointments (998)
FDA (20887)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1303)
Gene editing (180)
Generative AI (52)
Gene therapy (566)
GLP-1 (1039)
Government (5392)
Grass and pollen (8)
Guidances (374)
Healthcare (20939)
HIV (49)
Huntington's disease (41)
IgA nephropathy (67)
Immunology and inflammation (257)
Immuno-oncology (22)
Indications (59)
Infectious disease (3212)
Inflammatory bowel disease (192)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (198)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10151)
Liver cancer (92)
Longevity (13)
Lung cancer (592)
Lymphoma (286)
Machine learning (33)
Management (66)
Manufacturing (672)
MASH (146)
Medical device (14913)
Medtech (14940)
Mergers & acquisitions (22784)
Metabolic disorders (1190)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (237)
Neuropsychiatric disorders (63)
Neuroscience (2763)
NextGen: Class of 2025 (7687)
Non-profit (5098)
Now hiring (60)
Obesity (574)
Opinion (316)
Ovarian cancer (141)
Pain (172)
Pancreatic cancer (178)
Parkinson's disease (245)
Partnered (32)
Patents (429)
Patient recruitment (337)
Peanut (57)
People (66364)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23385)
Phase II (32887)
Phase III (24809)
Pipeline (2877)
Policy (302)
Postmarket research (3554)
Preclinical (10564)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (710)
Real estate (7423)
Recruiting (79)
Regulatory (28137)
Reports (65)
Research institute (2695)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (214)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1062)
Venture capital (68)
Weight loss (405)
Women's health (61)
Worklife (21)
Date
Today (311)
Last 7 days (985)
Last 30 days (3244)
Last 365 days (33717)
2025 (28327)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (309)
Arkansas (14)
Asia (51074)
Australia (8979)
California (9887)
Canada (2939)
China (948)
Colorado (415)
Connecticut (437)
Delaware (284)
Europe (117382)
Florida (1451)
Georgia (325)
Hawaii (3)
Idaho (67)
Illinois (830)
India (55)
Indiana (485)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (22)
Maine (79)
Maryland (1318)
Massachusetts (7392)
Michigan (320)
Minnesota (586)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2731)
New Mexico (32)
New York (2662)
North Carolina (1443)
North Dakota (10)
Northern California (4550)
Ohio (309)
Oklahoma (22)
Oregon (51)
Pennsylvania (2036)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (51)
South Dakota (1)
Southern California (3768)
Tennessee (153)
Texas (1547)
United States (36302)
Utah (298)
Virginia (255)
Washington D.C. (84)
Washington State (842)
West Virginia (4)
Wisconsin (102)
Wyoming (2)
There are 862,791 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akari Therapeutics’ Accepted Abstract Showcasing its Novel Splicing-Targeted ADC Payload Driving Immune Activation Now Available
November 5, 2025
·
7 min read
Press Releases
CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 5, 2025
·
6 min read
Press Releases
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager
November 5, 2025
·
9 min read
Press Releases
Enara Bio’s DARKFOX Discovery Propels ENA101, the First Ever Bispecific T Cell Engager Targeting a Cancer-Specific Dark Antigen, into IND-Enabling Studies
November 5, 2025
·
4 min read
Press Releases
Abalos Therapeutics to Present Preclinical Data Highlighting Potent, Synergistic Effects of ABX-001 in Combination with Bispecific T-cell Engagers at SITC 2025
November 5, 2025
·
3 min read
Press Releases
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China
November 5, 2025
·
6 min read
Press Releases
AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
November 5, 2025
·
2 min read
Press Releases
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
November 5, 2025
·
6 min read
Press Releases
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors
November 5, 2025
·
12 min read
Press Releases
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 5, 2025
·
4 min read
1 of 86,280
Next
